Table 1.
Clinicopathological characteristics and FUNDC1 expression in the cervical cancer patients
| Characteristics | FUNDC1 | P value | |
|---|---|---|---|
| Low expression, N (%) | High expression, N (%) | ||
| Age, years | 0.39 | ||
| <48 | 13 (15.9) | 20 (24.4) | |
| ≥48 | 24 (29.3) | 25 (30.5) | |
| FIGO stage | 0.56 | ||
| IA2 | 1 (1.2) | 1 (1.2) | |
| IB1 | 12 (14.6) | 9 (11.0) | |
| IB2 | 1 (1.2) | 5 (6.1) | |
| IIA | 19 (22.4) | 22 (26.8) | |
| IIB | 4 (4.7) | 8 (9.8) | |
| Tumor size, cm | 0.13 | ||
| <4 | 34 (41.5) | 36 (43.9) | |
| ≥4 | 3 (3.7) | 9 (10.8) | |
| Histology | 0.54 | ||
| SCC | 34 (41.5) | 41 (50.0) | |
| AC | 2 (2.4) | 1 (1.2) | |
| ASC | 1 (1.2) | 3 (3.7) | |
| Histological differentiation | 0.73 | ||
| Well | 2 (2.4) | 1 (1.2) | |
| Moderate | 28 (34.1) | 36 (43.9) | |
| Poor | 7 (8.5) | 8 (9.8) | |
| Deep stromal invasion | 0.73 | ||
| No | 4 (4.9) | 6 (7.3) | |
| Yes | 33 (40.2) | 39 (47.6) | |
| Lymphovascular space involvement | 0.98 | ||
| No | 32 (39.0) | 39 (47.6) | |
| Yes | 5 (6.1) | 6 (7.3) | |
| Positive parametrium | 0.37 | ||
| No | 33 (40.2) | 37 (45.1) | |
| Yes | 4 (4.9) | 8 (9.8) | |
| Positive surgical margin | 0.45 | ||
| No | 35 (42.7) | 44 (53.7) | |
| Yes | 2 (2.4) | 1 (1.2) | |
| LNM | 0.39 | ||
| No | 25 (30.5) | 25 (30.5) | |
| Yes | 6 (7.3) | 13 (15.9) | |
| Chemotherapy | 0.68 | ||
| No | 1 (1.2) | 2 (2.4) | |
| Yes | 36 (43.9) | 43 (52.4) | |
| Radiotherapy | 1 | ||
| No | 0 (0.0) | 0 (0.0) | |
| Yes | 37 (45.1) | 45 (54.9) | |
SCC, squamous cell carcinoma; AC, adenocarcinoma; ASC, adenosquamous carcinoma; LNM, lymph node metastasis.